Khaled M. Musallam

14.7k total citations · 4 hit papers
173 papers, 6.7k citations indexed

About

Khaled M. Musallam is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Khaled M. Musallam has authored 173 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Genetics, 117 papers in Hematology and 18 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Khaled M. Musallam's work include Hemoglobinopathies and Related Disorders (121 papers), Iron Metabolism and Disorders (96 papers) and Blood groups and transfusion (37 papers). Khaled M. Musallam is often cited by papers focused on Hemoglobinopathies and Related Disorders (121 papers), Iron Metabolism and Disorders (96 papers) and Blood groups and transfusion (37 papers). Khaled M. Musallam collaborates with scholars based in Lebanon, Italy and United States. Khaled M. Musallam's co-authors include Alì Taher, Maria Domenica Cappellini, Faek R. Jamali, Donat R. Spahn, E. A. Rachmilewitz, Hani Tamim, Toby Richards, Elliott Vichinsky, Stefano Rivella and Frits R. Rosendaal and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Khaled M. Musallam

166 papers receiving 6.5k citations

Hit Papers

Preoperative anaemia and postoperative outcomes in non-ca... 2011 2026 2016 2021 2011 2017 2019 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
    2011 806 citations Khaled M. Musallam, Alì Taher et al. profile →
  2. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
    2017 321 citations Maria Domenica Cappellini, Alì Taher et al. American Journal of Hematology profile →
  3. Iron deficiency anaemia revisited
    2019 294 citations Maria Domenica Cappellini, Khaled M. Musallam et al. profile →
  4. β-Thalassemias
    2021 234 citations Alì Taher, Khaled M. Musallam et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khaled M. Musallam Lebanon 42 4.2k 4.2k 714 707 603 173 6.7k
Paula Bolton‐Maggs United Kingdom 43 1.9k 0.4× 4.5k 1.1× 660 0.9× 613 0.9× 650 1.1× 158 6.7k
Peter W. Collins United Kingdom 60 2.6k 0.6× 8.0k 1.9× 879 1.2× 1.2k 1.7× 543 0.9× 252 11.9k
Michael Auerbach United States 38 1.9k 0.4× 3.1k 0.7× 345 0.5× 266 0.4× 245 0.4× 110 4.8k
Anatole Besarab United States 45 1.5k 0.4× 3.6k 0.9× 1.4k 1.9× 304 0.4× 357 0.6× 182 8.5k
Miguel R. Abboud Lebanon 36 4.7k 1.1× 4.3k 1.0× 373 0.5× 1.5k 2.1× 634 1.1× 188 7.2k
Mehran Karimi Iran 37 3.1k 0.7× 3.4k 0.8× 236 0.3× 739 1.0× 447 0.7× 364 5.7k
Daniel W. Coyne United States 39 1.1k 0.3× 1.8k 0.4× 484 0.7× 462 0.7× 370 0.6× 122 5.1k
Manuel Múñoz Spain 40 1.1k 0.3× 2.6k 0.6× 1.1k 1.5× 291 0.4× 260 0.4× 119 5.3k
Marsha Wolfson United States 21 596 0.1× 1.9k 0.4× 529 0.7× 452 0.6× 378 0.6× 59 4.2k
Rezan A. Kadir United Kingdom 46 1.3k 0.3× 3.2k 0.8× 738 1.0× 1.7k 2.4× 63 0.1× 163 6.3k

Countries citing papers authored by Khaled M. Musallam

Since Specialization
Citations

This map shows the geographic impact of Khaled M. Musallam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled M. Musallam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled M. Musallam more than expected).

Fields of papers citing papers by Khaled M. Musallam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled M. Musallam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled M. Musallam. The network helps show where Khaled M. Musallam may publish in the future.

Co-authorship network of co-authors of Khaled M. Musallam

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled M. Musallam. A scholar is included among the top collaborators of Khaled M. Musallam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled M. Musallam. Khaled M. Musallam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taher, Alì, Vip Viprakasit, Antonis Kattamis, et al.. (2025). Efficacy and safety of luspatercept in non–transfusion-dependent β-thalassemia: long-term results from the BEYOND study. Blood Advances. 9(23). 6108–6119.
2.
Musallam, Khaled M., Angela Vitrano, Rosario Di Maggio, et al.. (2025). Impact of lifetime anaemia and iron control on outcomes in β‐thalassaemia: Data from the longitudinal de‐LIGHT study. British Journal of Haematology. 207(4). 1578–1588.
3.
Musallam, Khaled M., Sujit Sheth, Thomas D. Coates, et al.. (2025). Non‐Transfusion‐Dependent Thalassemia: An Image Gallery Worth a Thousand Words. American Journal of Hematology. 100(4). 687–694.
4.
Musallam, Khaled M., et al.. (2024). Trans-acting genetic modifiers of clinical severity in heterozygous β-Thalassemia trait. Annals of Hematology. 103(11). 4437–4447. 1 indexed citations
5.
Musallam, Khaled M., Susanna Barella, Raffaella Origa, et al.. (2024). Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study. Annals of Hematology. 103(7). 2283–2297. 6 indexed citations
6.
Musallam, Khaled M., Susanna Barella, Raffaella Origa, et al.. (2024). Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent β-thalassemia patients who remained on the same monotherapy over 10 years. Blood Cells Molecules and Diseases. 107. 102859–102859. 5 indexed citations
7.
Saliba, Antoine N., Khaled M. Musallam, & Alì Taher. (2023). How I treat non-transfusion-dependent β-thalassemia. Blood. 142(11). 949–960. 14 indexed citations
8.
Musallam, Khaled M., Alì Taher, Antonis Kattamis, et al.. (2023). Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy. Drug Design Development and Therapy. Volume 17. 1583–1591. 5 indexed citations
9.
Musallam, Khaled M., Susanna Barella, Raffaella Origa, et al.. (2023). Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent β-thalassemia. Blood. 143(10). 930–932. 11 indexed citations
10.
Forni, Gian Luca, Barbara Gianesin, Khaled M. Musallam, et al.. (2023). Overall and complication‐free survival in a large cohort of patients with β‐thalassemia major followed over 50 years. American Journal of Hematology. 98(3). 381–387. 25 indexed citations
11.
Taher, Alì, Khaled M. Musallam, Vip Viprakasit, et al.. (2023). Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia. BMJ Open. 13(3). e066683–e066683. 4 indexed citations
12.
Al‐Shamsi, Humaid O., et al.. (2023). Arab Countries and Oncology Clinical Trials: A Bibliometric Analysis. Cancers. 15(18). 4428–4428.
13.
Cappellini, Maria Domenica, John B. Porter, Khaled M. Musallam, et al.. (2015). Development of a new disease severity scoring system for patients with non-transfusion-dependent thalassemia. European Journal of Internal Medicine. 28. 91–96. 10 indexed citations
14.
Lotta, Luca A., Haifeng Wu, Khaled M. Musallam, & Flora Peyvandi. (2013). The emerging concept of residual ADAMTS13 activity in ADAMTS13-deficient thrombotic thrombocytopenic purpura. Blood Reviews. 27(2). 71–76. 12 indexed citations
15.
Taher, Alì, Vip Viprakasit, Khaled M. Musallam, & Maria Domenica Cappellini. (2013). Treating iron overload in patients with non‐transfusion‐dependent thalassemia. American Journal of Hematology. 88(5). 409–415. 53 indexed citations
16.
17.
Succar, Julien, Khaled M. Musallam, & Alì Taher. (2011). THALASSEMIA AND VENOUS THROMBOEMBOLISM. SHILAP Revista de lepidopterología. 3(1). e2011025–e2011025. 35 indexed citations
18.
Arnaout, Samir, et al.. (2011). ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST. SHILAP Revista de lepidopterología. 3(1). e2011023–e2011023. 2 indexed citations
19.
Musallam, Khaled M., et al.. (2009). Solitary Hydatid Cyst of the Thigh: A Challenging Diagnosis. Vector-Borne and Zoonotic Diseases. 9(6). 743–745. 5 indexed citations
20.
Mansour, Khaled, Alì Taher, Khaled M. Musallam, & Samir Alam. (2009). Aspirin Resistance. Advances in Hematology. 2009. 1–10. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula Bolton‐Maggs Breakdown of academic impact, for papers by Peter W. Collins Breakdown of academic impact, for papers by Michael Auerbach Breakdown of academic impact, for papers by Anatole Besarab Breakdown of academic impact, for papers by Miguel R. Abboud Breakdown of academic impact, for papers by Mehran Karimi Breakdown of academic impact, for papers by Daniel W. Coyne Breakdown of academic impact, for papers by Manuel Múñoz Breakdown of academic impact, for papers by Marsha Wolfson Breakdown of academic impact, for papers by Rezan A. Kadir
Rankless by CCL
2026